GO-DS21 - Gene overdosage and comorbidities during the early lifetime in Down Syndrome

Strydom, Andre (Primary Investigator)
Gulliford, Martin (Co-Investigator)

Project: Research

Status	Active
Effective start/end date	1/01/2020 → 31/12/2024

Collaborative partners

King's College London
Centre Européen de Recherche en Biologie et en Médecine (lead)
ICM Institut du cerveau et de la moelle épinière
CRG Centre for Genomic Regulation
Queen Mary University of London
Helmholtz Zentrum München GmbH
Jérôme Lejeune Institute
Hospital del Mar Institute of Medical Research
University of Cambridge
Trisomy 21 Research Society
Perha Pharmaceuticals SAS

Funding

EC European Commission: £5,011,413.00